Eni has approved the final investment decision for a new biorefinery at the Sannazzaro de’ Burgondi refinery in Italy, complementing the Priolo biorefinery project and expanding Enilive’s renewable ...
Novartis has announced plans to establish a 46,000-square-foot radioligand therapy manufacturing facility in Denton, Texas, with operations expected to begin in 2028. The new site will expand the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results